INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.58B / 21S · 3 late79 trades$24.55M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

18,675 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
OJ
O Connor Kevin JDirector
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$314K
5,769 sh
Oct 6, 2026Oct 7, 2026
Page 71 of 467
← PrevNext →

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUY
traded Oct 6, 2026
+1d
SEC Form 4

Evidence

22
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$464K
4,284 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

22
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$318K
2,921 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

22
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$1.66M
7,548 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

22
CE
Colburn Richard Edward IIIChief Product & Tech Officer
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$298K
4,178 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

22
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$1.37M
6,188 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

21
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$411K
4,100 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

20
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Open-market sale · 10b5-1 plan
SELL$1.65M
19.0K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

19
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$504K
2,298 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

19
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$682K
3,068 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

19
OJ
O Connor Kevin JDirector
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$106K
1,923 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

19
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$849K
3,798 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

19
HA
Hudson Scott AEVP & President Vistra Retail
VSTVistra Corp.
Open-market sale · 10b5-1 plan
SELL$3.56M
22.2K sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

19
CJ
Camblong JurgiDirector, Executive Chairman
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$327K
40.2K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

19
GM
Gallagher Daniel Martin JrChief Legal Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$536K
4,700 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

19
GM
Gallagher Daniel Martin JrChief Legal Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$544K
4,800 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

19
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$236K
2,200 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

19
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$516K
2,300 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

19
WJ
Wassil JimEVP, Chief Scientific Ofc, COO
PCVXVaxcyte, Inc.
Open-market sale · 10b5-1 plan
SELL$1.56M
18.0K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

18
RL
Reierson Amanda LDirector
PRCHPorch Group, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
8,501 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

18
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,418 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

17
MJ
Maetzold Derek JDirector, Pres. & Chief Exec. Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$305K
8,580 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

17
Neri Antonio FDirector, President and CEO
HPEHewlett Packard Enterprise Co
Open-market sale · 10b5-1 plan
SELL$13.20M
193.3K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

17
CW
Cooper Matthew WGeneral Counsel & Corp Secy
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$687K
3,500 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

16
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$64K
300 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

16
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$225K
1,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

16
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$64K
300 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$60K
7,394 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

16
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$620K
50.0K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$50K
6,168 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

16
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$88K
580 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

16
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$64K
424 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$60K
7,394 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

16
GM
Gallagher Daniel Martin JrChief Legal Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
500 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

16
AJ
Allaire JeremyDirector, Chairman and CEO
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.77M
33.1K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

16
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$86K
35.0K sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

16
MR
Muken RossDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$80K
9,838 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

15
TR
ten Bosch John RoderickSVP of Laboratory Operations
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,417 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

15
TR
ten Bosch John RoderickSVP of Laboratory Operations
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,417 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

15
PM
Parisotto Shannon MCEVP, Disc & Safety Assessment
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Open-market sale · 10b5-1 plan
SELL$303K
981 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

UPBDUPBOUND GROUP, INC.Nov 2 – Nov 3
7 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  • BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  • SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K